<DOC>
	<DOCNO>NCT02117843</DOCNO>
	<brief_summary>The study Prospective , Multi-center , Single Armed Registry Evaluate The Safety Efficacy 'AVI ' Stent Treating Coronary Revascularization .</brief_summary>
	<brief_title>The Safety Efficacy 'AVI ' Stent Treating Coronary Revascularization</brief_title>
	<detailed_description>The study Prospective , Multi-center , Single Armed Registry Evaluate The Safety Efficacy 'AVI ' Stent Treating Coronary Revascularization , 1200 primary coronary artery disease patient enrol , approximately 40 site . Subject follow-up occur via telephone contact clinical visit 30 day , 6 month , 9 month , 12 month , 2-5 year procedure .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Arsenic trioxide</mesh_term>
	<criteria>Patient must least 18 year age ; Ischemic heart symptom and/or myocardial ischemia , include chronic stable/unstable coronary artery disease acute coronary syndrome ( ST elevate MI NonST elevate MI ) ; At least one lesion diameter stenosis &gt; 70 % suitable coronary stent implantation vessel reference diameter range 2.5mm 3.5mm ; If subject multiple vessel lesion , implanted stent must brand . The staged procedure allow within 3 month procedure , implanted stent must brand stent index procedure ; Subject CABG contraindication ; Subject legal representative inform property study , understand stipulation protocol , ensure compliance sign ICF ; Pregnant nursing patient plan become pregnant 1 year post index procedure ; Subject tendency bleed coagulation disorder , contraindication antiplatelet and/or anticoagulant therapy , ca n't accept continue DAPT within 6 month ; Poor compliance expectation life less 1 year ; Implanted brand stent target vessel within 1 year ; Left Ventricular Ejection Fraction ( LVEF ) ï¼œ30 % ; Cardiogenic shock haemodynamics abnormal , need inotropic agent mechanical support ; The subject allergic asprin , heparin , clopidogrel/ticlopidine , stainless steel alloy , arsenic trioxide , sirolimus , styrenebutenestyrene polylactic acid ( PLA ) polymer contrast agent ; Severe tortuous and/or heavy calcification lesion ; Two proximal chronic total occlusion lesion ; Bifurcation lesion double stent ; The subject multivessel lesion implant brand stent ; The subject investigator considers he/she unfit implant AVI stent Firebird 2 stent ; The subject attend drug/device study followup period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>